Salarius Pharmaceuticals Inc (NASDAQ:SLRX) Stock Boosted By Q1 Earnings
This morning the price action in the Salarius Pharmaceuticals Inc (NASDAQ:SLRX) stock could be of interest to many investors. Although the stock had managed to clock gains of as much as 39% on Thursday, it should be noted that it suffered from a heavy selloff in premarket trading and went down by as much as 18%. Trading Data On Thursday, SLRX stock surged 39% to $0.2220 with more than 12.85…